← Leaderboards
Curtis Clark
University Of Texas Hlth Science Center
$117,588
Attributed
$117,588
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $40K · FY2016–19$50K$37.5K$25K$12.5K$0
'16
'17
'18
'19
Funding mix
By agency
NIH$117,588 · 1
By mechanism
F30$117,588 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Science Center
Same institution · by research overlap
- Laurence Morel$26,519,374
- Shai Shlomo Shen-Orr$5,881,797
- Paolo Casali$21,552,235
- Suzette Laing$222,750
- Anand Kornepati$129,544
Others in their field
Top investigators on “Immune Resistance”
- Judith S. Currier · University Of California Los Angeles$243,950,834
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$172,075,623
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- Daniel R Kuritzkes · Brigham And Women'S Hospital$109,216,405
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$103,430,446
- Peter C Adamson · National Childhood Cancer Foundation$89,977,097
Research focus
Immune ResistanceImmuneAffectGrowthBaseBeta CateninBiological Response ModifiersBlocking AntibodiesAutophagocytosisCancer ImmunotherapyCancer Stem CellCcl2 GeneCd44 GeneCellsClinical EfficacyCombined Modality TherapyCxcl12 GeneDistalDistantEngineeringFailureFrap1 GeneGene TherapyImmunity
Grant awards (4)
Novel PD-L1 signals regulating anti-tumor immunity and immunotherapy responses$6,236
F30 · FY2019 · CA · contact PI
Novel PD-L1 signals regulating anti-tumor immunity and immunotherapy responses$40,028
F30 · FY2018 · CA · contact PI
Novel PD-L1 signals regulating anti-tumor immunity and immunotherapy responses$39,548
F30 · FY2017 · CA · contact PI
Novel PD-L1 signals regulating anti-tumor immunity and immunotherapy responses$31,776
F30 · FY2016 · CA · contact PI